The 1st International Electronic Conference on Vaccines

Dear colleagues,

We are pleased to announce the 1st International Electronic Conference on Vaccines: RNA Vaccines, Current Challenges and Future Developments (IECV 2023), which will be held on 1–15 December 2023.

mRNA vaccines have been developed and trialled for cancers and infectious diseases. Although the success of mRNA vaccines has been achieved in the control of COVID-19, there are challenges for future development. The production of mRNA vaccines requires multiple steps including mRNA synthesis, purification, and formulation with, e.g., lipid nanoparticles. Therefore, the stability of intermediate and final products during storage and transportation is a real problem. Breakthrough infections of SARS-CoV-2 variants and the immune evasion of cancers driven by the mutation of antigens expressed from mRNA are the major challenges in development. Since mRNA vaccines have shown advantages compared to others due to the induction of humoral and cellular immune responses and adaptability in viral and tumour antigens, future vaccines should be stabler, safer, and more compatible with other regimens in combination with other options.

All vaccine-related scientists or researchers are welcome to join this event and share their findings around the following general and related themes including but not limited to:

• Vaccines to counter anti-microbial resistance;
• Vaccines to eradicate endemic disease-opportunities and challenges;
• Vaccines to prevent zoonotic transmission-targeting the animal reservoir;
• Vaccine platforms—advantages and disadvantages;
• Clinical trial design for reactive and preventive vaccination;
• Vaccine deployment in outbreak settings—lessons learned;
• Advances in vaccine formulation and adjuvantisation;
• Clinical view on routinisation of RNA vaccines;
• How do we prepare for vaccines against the as yet unknown?;
• COVID-19 Vaccine Hesitancy;
• Immune Response after Vaccination against SARS-CoV-2 in Patients with Chronic Diseases;
• T Cell Responses in SARS-CoV-2;
• SARS-CoV-2 Variant and Vaccines Development;
• Novel Technology and Vaccines Development for COVID-19;
• T Cell Immunity and HIV-1 Pathogenicity;
• Neurological Complications Following COVID-19 Infection and COVID-19 Vaccination;
• Vaccine hesitancy;
• Vaccine safety;
• Vaccine ingredients;
• Vaccine schedule;
• Vaccine objections;
• Vaccines influence on education;
• Cost-Effectiveness of vaccines;
• Vaccine transportation;
• Methods of Vaccination;
• Vaccine-related policy.

The participants will have the opportunity to examine, explore, and critically engage with issues and advances in these areas. We hope to facilitate discussions and exchanges within the community. This event will solely be an online proceeding, which allows for participation from all over the world with no concerns about travel and related expenditures. This type of conference is particularly appropriate and useful because research concerned with vaccines is progressing rapidly and globally. An electronic conference provides a platform for rapid and direct exchanges about the latest research findings and novel ideas. Participation in as well as the “attendance” of this online conference is free of charge.

We hope that the community will share this enthusiasm and help ensure this conference a success.

The Chair of the 1st International Electronic Conference on Vaccines: RNA Vaccines, Current Challenges and Future Developments

Follow the conference organizer on Social Media